Matrix type transdermal drug delivery systems of metoprolol tartrate: In vitro characterization

Acta Pharmaceutica

Volumn 53, Issue 2, 2003, Pages 119-125

  Aqil, Mohamed ^a   Sultana, Yasmin ^a   Ali, Asgar ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

In vitro permeation; In vitro release; Matrix system; Metoprolol tartrate; Transdermal drug delivery

Indexed keywords

2 PROPANOL; DICHLOROMETHANE; DIMETHYL SULFOXIDE; EUDRAGIT; EXCIPIENT; MACROGOL 400; MERCURY; METOPROLOL TARTRATE; POVIDONE;

ANIMAL TISSUE; ARTICLE; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; FILM; IN VITRO STUDY; METHODOLOGY; NONHUMAN; RAT; SKIN PERMEABILITY;

EID: 0038504598     PISSN: 13300075     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. J. R. Robinson and V. H. Lee, Controlled Drug Delivery: Fundamentals and Applications, Marcel Dekker, New York 1987, pp 523-552.
2. B. W. Barry, Dermatological Formulation, Marcel Dekker, New York 1983, pp. 225-238.
3. R. M. Pai, M. S. Desai, A. D. Babtiwale and R. Shrivastava, Adhesive matrix type transdermal drug delivery system for nitroglycerin, Drug Dev. Ind. Pharm. 20 (1994) 1905-1909.
4. J. Singh, K. P. Tripathi and T. R. Sakia, Effect of penetration enhancers on the in vitro transport of ephedrine through rat skin and human epidermis from matrix based transdermal formulations, Drug Dev. Ind. Pharm. 19 (1993) 1623-1628.
5. C. Valenta and I. Almasi-Szabo, In vitro diffusion studies of ketoprofen transdermal therapeutic system, Drug Dev. Ind. Pharm. 21 (1995) 1799-1805.
6. R. Krishna and J. K. Pandit, Transdermal delivery of propranolol, Drug Dev. Ind. Pharm. 20 (1994) 2459-2465.
7. A. Jarvinen, A. Backstrom, C. Elfstorm and A. Viitanen, Comparative absorption and variability in absorption of estradiol from a transdermal gel and a novel matrix-type transdermal patch, Maturitas 38 (2001) 189-196.
8. C. Dollery, Therapeutic Drugs, Churchill Livingstone, New York 1991, pp. 115-118.
9. The United States Pharmacopoeia, 23rd ed., US Pharmacopoeial Convention Rockvile 1999, pp. 1796-1799.
10. T. Franz, Percutaneous absorption. On the relevance of in vitro data, J. Invest. Dermatol. 64 (1975) 190-195.
11. A. Ali, S. Rada and S. P. Aggarwal, Fabrication of a diffusion cell for the determination of drug released from topical aerosol formulations, Indian Drugs 34 (1997) 715-717.
12. F. P. Bonina, V. Carellii, G. D. Cols, L. Montenegro and E. Nannipieri, Vehicle effects on in vitro skin permeation of and stratum corneum affinity for model drugs caffeine and testosterone, Int. J. Pharm. 100 (1993) 41-47.
13. R. Bhushan and G. T. Thiongo, Direct enantio-separation of some β-adrenergic blocking agents using impregnated TLC, J: Chromatogr. Biomed Sci. Appl. 708 (1998) 330-334.
14. S. Singh, Drug stability testing and shelf life determination according to international guidelines, Pharm. Tech. 23 (1999) 68-88.